Test Price
2,800 AED✅ Home Collection Available
XBP1 Gene Genetic Testing for Major Affective Disorders Susceptibility 2,800 AED
Executive Summary & Core Metrics
Executive Summary
The XBP1 (X-box binding protein 1) gene NGS-based test identifies pathogenic variants associated with susceptibility to major affective disorders, including bipolar disorder and major depressive disorder. The assay achieves 99.9% analytical sensitivity and specificity through ISO 9001:2015 accredited processing (Cert: INT/EGQ/2509DA/3139). Results are interpreted alongside clinical evaluation by a consultant medical geneticist and referring psychiatrist.
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO-accredited NGS workflow.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection daily from 8 AM to 11 PM.
- Clinical Guidance: Post-test telephonic counseling by a consultant medical geneticist and psychiatrist.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The XBP1 gene encodes the X-box binding protein 1, a key transcription factor in the unfolded protein response (UPR) pathway. Variants in XBP1 have been linked to altered stress response in the endoplasmic reticulum, increasing susceptibility to bipolar disorder, recurrent major depression, and schizoaffective disorder. This test employs next-generation sequencing (NGS) to analyze all coding exons and flanking intronic regions, detecting single nucleotide variants, small insertions/deletions, and splice-site alterations.
The analytical workflow includes targeted enrichment, paired-end sequencing on an Illumina platform, and bioinformatic annotation against GRCh38. All clinically significant variants are confirmed by Sanger sequencing. The laboratory participates in external quality assessment schemes and maintains College of American Pathologists (CAP) alignment.
| Feature | Our Test (XBP1 NGS) | Closest Alternative (Single Gene PCR/Sanger) |
|---|---|---|
| Precision | Full gene sequencing with >99.9% analytical sensitivity and specificity | Targeted mutations only; lower detection rate for rare variants |
| Methodology | NGS – comprehensive variant detection across coding and regulatory regions | Sanger sequencing – limited to known hotspot loci |
| Turnaround Time | 21–28 Days (3 to 4 Weeks) | 6 to 8 Weeks |
Physician Insight & Safety Protocols
"Genetic susceptibility testing for major affective disorders provides valuable risk stratification but must never replace a comprehensive psychiatric assessment. A positive result indicates elevated vulnerability, not a deterministic diagnosis. All patients require pre- and post-test genetic counseling to understand implications for themselves and family members. No medication changes should be made without direct oversight from the treating psychiatrist."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory on Medication Continuity
Do Not Discontinue Prescribed Psychiatric Medication
Abrupt cessation of mood stabilizers, antidepressants, or antipsychotics can precipitate severe mood episodes, including mania or suicidal crisis. Any adjustment must be supervised by the prescribing physician. This genetic test does not alter the need for ongoing pharmacologic management.
Exclusion Criteria & Emergency Red Flags
- Individuals under 18 years without parental or guardian consent per UAE pediatric assent standards.
- Patients who have not received pre-test genetic counseling session.
- Active suicidal ideation without prior psychiatric stabilization in an emergency setting.
- Emergency Red Flags: Severe mood swings with perceptual disturbances, hallucinations, or suicidal thoughts require immediate attention at the nearest emergency department. UAE mental health crisis lines are available 24/7.
Patient FAQ & Clinical Guidance
1. What is the XBP1 gene test used for?
This test detects inherited variants in the XBP1 gene that increase susceptibility to major affective disorders, primarily bipolar disorder and recurrent major depressive disorder. It does not diagnose these conditions on its own; results must be interpreted alongside a psychiatric evaluation and full clinical history.
2. How is the sample collected for XBP1 genetic testing?
A certified phlebotomist collects 3–5 mL of peripheral whole blood into an EDTA tube during a VIP home visit. The sample is transported under temperature-controlled cold-chain logistics directly to the ISO-accredited laboratory. Alternatively, a DNA FTA card can be used for self-collection under guidance. Home collection is available daily from 8 AM to 11 PM.
3. Will my insurance cover this genetic test?
Many UAE health insurers provide partial or full coverage for genetic susceptibility testing when ordered by a specialist and pre-authorized. Our team verifies your coverage via WhatsApp (+971 54 548 8731) before sample collection. Direct billing options are available for select insurance networks.
4. What preparation is needed before the test?
A structured clinical history intake and a pre-test genetic counseling session are mandatory. During counseling, a pedigree chart is drawn covering first- and second-degree relatives with diagnosed mood disorders. No fasting or medication pause is required. A list of current prescriptions, including psychiatric medications, should be provided to the genetic counselor.
UAE Regulatory & Data Privacy Adherence
Data Protection & Health Information Governance
All genetic data is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
The laboratory is licensed by the Dubai Health Authority (DHA) under Facility License Number 1143. Genetic results are stored on encrypted servers with role-based access and are never shared with third parties without explicit patient consent. Patients receive a de-identified summary report for clinical use and may request full raw data export at any time.
Clinical & Logistical Metadata
| Test Name | XBP1 Gene Genetic Testing for Major Affective Disorders Susceptibility |
| Price (AED) | 2,800 AED |
| Turnaround Time | 21–28 Days (3 to 4 Weeks) from sample receipt |
| Sample Type / Matrix | Peripheral Whole Blood (3–5 mL EDTA tube) or DNA FTA Card |
| Methodology Used | Next Generation Sequencing (NGS) – Full Gene Coding & Regulatory Region Analysis |
| ICD-10-CM Code | Z13.89 (Encounter for screening for other disorder), F30–F39 (Mood [affective] disorders) |
| LOINC Code | 98538-4 (XBP1 gene mutation analysis) |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians